Ataxia Telangiectasia Mutated (ATM) (Ser1981) Peptide
-
- Target See all ATM products
- ATM (Ataxia Telangiectasia Mutated (ATM))
- Protein Region
- Ser1981
-
Source
- Synthetic
- Application
- Control Peptide (CP)
- Characteristics
- control peptide, blocking peptide, ATM, AT mutated, AT protein, AT1, ATA, Ataxia telangiectasia gene mutated in human beings, Ataxia telangiectasia mutated, ATC
- Purity
- Greater than 95% specific peptide
-
-
- Application Notes
-
Application Note: Control peptide should be used at 1.0 μg per 1.0 μL of antiserum in per assay.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 1.0 mg/mL
- Buffer
-
Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2
0.01 % (w/v) Sodium AzideStabilizer: None
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Storage
- RT,4 °C,-20 °C
- Expiry Date
- 6 months
-
- Target
- ATM (Ataxia Telangiectasia Mutated (ATM))
- Synonyms
- ATM Peptide, Atm Peptide, CG6535 Peptide, Dmel\\CG6535 Peptide, Tefu Peptide, atm Peptide, atm/tefu Peptide, dATM Peptide, tef Peptide, Xatm Peptide, at1 Peptide, atdc Peptide, tel1 Peptide, telo1 Peptide, AT1 Peptide, ATA Peptide, ATC Peptide, ATD Peptide, ATDC Peptide, ATE Peptide, TEL1 Peptide, TELO1 Peptide, AI256621 Peptide, C030026E19Rik Peptide, telomere fusion Peptide, ATM serine/threonine kinase L homeolog Peptide, ATM serine/threonine kinase Peptide, ataxia telangiectasia mutated Peptide, ataxia telangiectasia mutated (atm) Peptide, serine/threonine-protein kinase ATM Peptide, tefu Peptide, atm.L Peptide, atm Peptide, ATM Peptide, EDI_100660 Peptide, CpipJ_CPIJ001772 Peptide, BDBG_08252 Peptide, PAAG_02532 Peptide, MCYG_05088 Peptide, VDBG_06833 Peptide, ACLA_015700 Peptide, LOC5565620 Peptide, MGYG_07634 Peptide, PGTG_14279 Peptide, Atm Peptide
-